Agenda for 28 May 2014 Transparency Commission meeting

The agenda for the 28 May 2014 Transparency Commission meeting is now available.  The Commission will examine the following health ...

Read more →

NICE recommends lubiprostone to treat long-term, painful constipation

NICE has recommended lubiprostone (Amitiza, Sucampo Pharma Europe) as a treatment option for chronic idiopathic constipation in adults. ...

Read more →

PBS Publications - design changes to PDF documents

The Schedule of Pharmaceutical Benefits is provided in a variety of formats including PDF versions of both the monthly schedule and ...

Read more →

Novo Nordisk changes strategy in Germany, launches diabetes drug

Danish drugmaker Novo Nordisk, the world's biggest insulin producer, said on Wednesday it had decided to launch its diabetes drug ...

Read more →

Decision to list tobramycin powder and widen access to clarithromycin infusion

PHARMAC is pleased to announce a decision to list tobramycin powder and widen access to clarithromycin infusion. In summary, the ...

Read more →

Calls for UK to pilot new reimbursement models for antibiotics

 8 July 2014 - Pharmaceutical industry leaders are calling for an alternative reimbursement model for antibiotics in the UK sooner ...

Read more →

Roche blasts U.K. drug watchdogs for limiting use of Tarceva in lung cancer

[:content [\4 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \  \N \I \C \E \space \i \s \space \n \o \space \l \o \n \g \e \r \space \r \e \c \o \m \m \e \n \d \i \n \g \space \t \h \a \t \space \R \o \c \h \e \' \s \  \t \a \r \g \e \t \e \d \space \l \u \n \g \space \c \a \n \c \e \r \space \d \r \u \g \  \T \a \r \c \e \v \a \  \( \e \r \l \o \t \i \n \i \b \space \h \y \d \r \o \c \h \l \o \r \i \d \e \) \space \b \e \space \u \s \e \d \space \a \s \space \a \space \s \e \c \o \n \d \- \l \i \n \e \space \t \r \e \a \t \m \e \n \t " ..."]]
Read more →

Restrictions on skin cancer drug

[:content [\2 \5 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \  \A \space \\ \" \l \i \f \e \- \e \x \t \e \n \d \i \n \g \\ \" \space \s \k \i \n \space \c \a \n \c \e \r \space \d \r \u \g \space \s \h \o \u \l \d \space \n \o \t \space \b \e \space \g \i \v \e \n \space \t \o \space \p \a \t \i \e \n \t \s \space \a \s \space \a \space \f \i \r \s \t \- \l \i \n \e \space \t \r \e \a \t \m \e \n \t \, \space \N \H \S \space \o \f \f \i \c \i \a \l \s " ..."]]
Read more →

Decision relating to the listing of diltiazem hydrochloride (Apo-Diltiazem)

PHARMAC is pleased to announce the approval of an agreement with Apotex NZ Limited relating to the supply of diltiazem ...

Read more →

Simeprevir has been approved in Canada as a new treatment for hepatitis C

[:content [\2 \0 \space \N \o \v \e \m \b \e \r \space \2 \0 \1 \3 \  \â \€ \” \space \M \e \d \i \v \i \r \  \h \a \s \space \a \n \n \o \u \n \c \e \d \space \t \h \a \t \space \H \e \a \l \t \h \space \C \a \n \a \d \a \space \h \a \s \space \a \p \p \r \o \v \e \d \space \s \i \m \e \p \r \e \v \i \r \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \space \c \h \r \o \n \i \c \space \h \e \p \a \t \i \t \i \s \  \C \space \( \C \H \C \) \space \g \e \n \o \t \y \p \e \space \1 " ..."]]
Read more →

Post-market review of Authority Required PBS listings - opioids roundtable meeting

The Department of Health will hold an Opioids Roundtable meeting in Canberra on Wednesday, 27 May 2015, to assist the PBAC to ...

Read more →

EMA and Australian regulatory authority strengthen collaboration in the area of orphan medicines

At a meeting at the European Medicines Agency (EMA) office on 4 April 2014, the EMA's Executive Director Prof Guido ...

Read more →

Avastin on CDF list for advanced cervical cancer

[:content [\6 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  \P \a \t \i \e \n \t \s \space \w \i \t \h \space \a \d \v \a \n \c \e \d \space \c \e \r \v \i \c \a \l \space \c \a \n \c \e \r \space \i \n \space \E \n \g \l \a \n \d \space \h \a \v \e \space \b \e \e \n \space \g \i \v \e \n \space \t \h \e \space \c \h \a \n \c \e \space \o \f \space \a \c \c \e \s \s \i \n \g \space \t \r \e \a \t \m \e \n \t \space \w \i \t \h \space \R \o \c \h \e \' \s " ..."]]
Read more →

NICE gives green light to Lucentis (ranibizumab) for eye condition in final draft guidance

[:content [\N \I \C \E \space \h \a \s \space \i \s \s \u \e \d \space \f \i \n \a \l \space \d \r \a \f \t \space \g \u \i \d \a \n \c \e \space \r \e \c \o \m \m \e \n \d \i \n \g \space \t \h \e \space \u \s \e \space \o \f \  \L \u \c \e \n \t \i \s \space \( \r \a \n \i \b \i \z \u \m \a \b \) \  \a \s \space \a \space \t \r \e \a \t \m \e \n \t \space \o \p \t \i \o \n \space \f \o \r \space \s \i \g \h \t \space \p \r \o \b \l \e \m \s \space \c \a \u \s \e \d \space \b \y \space \n \e \w " ..."]]
Read more →

Price cut call as cancer drug rejected for routine NHS use

Drug manufacturers have been accused of demanding too much money for life-extending medication after a second cutting-edge breast cancer treatment within ...

Read more →